Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samba-02: Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes
2013-003042-16Phase 2Completed
- Sponsor
- Aerami Therapeutics
- Start
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of human insulin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Aerami Therapeutics. Started Jul 2013; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-003042-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003042-16.